Certified by Founder Lodge
Sionna Therapeutics
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $182,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecul
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 07 ,2024 | Series C | $182,000,000 |
Atlas Venture
Viking Global Investors
T. Rowe Price
Enavate Sciences
Perceptive Advisors
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Allos | $5,000,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
